PMID- 25444646 OWN - NLM STAT- MEDLINE DCOM- 20160321 LR - 20220409 IS - 1989-1342 (Electronic) IS - 1888-4296 (Print) IS - 1989-1342 (Linking) VI - 8 IP - 3 DP - 2015 Jul-Sep TI - Corneal Regeneration After Photorefractive Keratectomy: A Review. PG - 149-69 LID - S1888-4296(14)00086-7 [pii] LID - 10.1016/j.optom.2014.09.001 [doi] AB - Photorefractive keratectomy (PRK) remodels corneal stroma to compensate refractive errors. The removal of epithelium and the ablation of stroma provoke the disruption of corneal nerves and a release of several peptides from tears, epithelium, stroma and nerves. A myriad of cytokines, growth factors, and matrix metalloproteases participate in the process of corneal wound healing. Their balance will determine if reepithelization and stromal remodeling are appropriate. The final aim is to achieve corneal transparency for restoring corneal function, and a proper visual quality. Therefore, wound-healing response is critical for a successful refractive surgery. Our goal is to provide an overview into how corneal wounding develops following PRK. We will also review the influence of intraoperative application of mitomycin C, bandage contact lenses, anti-inflammatory and other drugs in preventing corneal haze and post-PRK pain. CI - Copyright (c) 2014 Spanish General Council of Optometry. Published by Elsevier Espana. All rights reserved. FAU - Tomas-Juan, Javier AU - Tomas-Juan J AD - Department of Visual Science, VallmedicVision International Eye Clinic, Andorra. Electronic address: javier.tomas@vallmedicvision.com. FAU - Murueta-Goyena Larranaga, Ane AU - Murueta-Goyena Larranaga A AD - Collaborator Researcher at Department of Neuroscience, University of Basque Country, Leioa, Spain. FAU - Hanneken, Ludger AU - Hanneken L AD - Department of Visual Science, VallmedicVision International Eye Clinic, Andorra. LA - eng PT - Journal Article PT - Review DEP - 20141023 PL - Spain TA - J Optom JT - Journal of optometry JID - 101482903 RN - 0 (Alkylating Agents) RN - 0 (Anti-Inflammatory Agents) RN - 50SG953SK6 (Mitomycin) SB - IM MH - Alkylating Agents/administration & dosage MH - Anti-Inflammatory Agents/therapeutic use MH - Contact Lenses MH - Cornea/innervation/physiology MH - Corneal Opacity/etiology/prevention & control MH - Humans MH - Lasers, Excimer/therapeutic use MH - Mitomycin/administration & dosage MH - Photorefractive Keratectomy/*methods MH - Postoperative Complications/prevention & control MH - Regeneration/physiology MH - Wound Healing/*physiology PMC - PMC4502084 OTO - NOTNLM OT - Contact lenses OT - Cornea OT - Curacion de heridas OT - Cornea OT - Lentes de contacto OT - Photorefractive keratectomy OT - Queratectomia fotorrefractiva OT - Wound healing EDAT- 2014/12/03 06:00 MHDA- 2016/03/22 06:00 PMCR- 2014/10/23 CRDT- 2014/12/03 06:00 PHST- 2014/06/28 00:00 [received] PHST- 2014/08/01 00:00 [revised] PHST- 2014/12/03 06:00 [entrez] PHST- 2014/12/03 06:00 [pubmed] PHST- 2016/03/22 06:00 [medline] PHST- 2014/10/23 00:00 [pmc-release] AID - S1888-4296(14)00086-7 [pii] AID - 10.1016/j.optom.2014.09.001 [doi] PST - ppublish SO - J Optom. 2015 Jul-Sep;8(3):149-69. doi: 10.1016/j.optom.2014.09.001. Epub 2014 Oct 23.